AKT1 and myocardial infarction: To evaluate the therapeutic efficacy of AdMSCs engineered to overexpress PD-L1 and AKT (AdMSC-PD-L1-Akt) in attenuating MI-induced cardiac dysfunction, these cells were administered to rats immediately post-ligation of the left anterior descending artery (LAD).